ATHE Similar Chart Price Prediction
The price of ATHE is predicted to go up 7.86%, based on the high correlation periods with BG. The similarity of these two price pattern on the periods is 97.09%.
ATHE
BG
Up: 7.86%Similarity: 97.09%
ATHE Revenue Forecast
ATHE EPS Forecast
ATHE Analyst's Forecast
Jason McCarthy
Maxim Group
Strong Buy
2025-01-30
Price Target
$8 → $12
Upside
+140.92%
Maxim analyst Jason McCarthy raised the firm's price target on Alterity Therapeutics to $12 from $8 and keeps a Buy rating on the shares after the company reported Phase 2 data for lead asset ATH434 in patients with early-stage multiple system atrophy. The data are "mixed but overall positive," says the analyst, who adds that the relatively small trial should inform the design of a later-stage study.
Jason McCarthy
Maxim Group
Strong Buy
2024-12-12
Price Target
$8
Upside
+265.43%
